Glucocorticoid-induced leucine zipper (GILZ) antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  He, Linlin ^a,b   Yang, Nianlan ^a   Isales, Carlos M ^a   Shi, Xing Ming ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID INDUCED LEUCINE ZIPPER; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 SMURF1; UBIQUITIN PROTEIN LIGASE E3 SMURF2; UNCLASSIFIED DRUG; DSIP1 PROTEIN, MOUSE; ENZYME INHIBITOR; GLUCOCORTICOID; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETROVIRUS; ANIMAL; C57BL MOUSE; CYTOLOGY; INFLAMMATION; MALE; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL DIFFERENTIATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOCORTICOIDS; INFLAMMATION; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; OSTEOGENESIS; PHOSPHORYLATION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857771842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031717     Document Type: Article

References (38)

1. Locascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, et al. (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8: 39-51.
2. Nishimura J, Ikuyama S, (2000) Glucocorticoid-induced osteoporosis: pathogenesis and management. J Bone Miner Metab 18: 350-352.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 284: 143-147.
4. Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ, (2000) Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum 43: 2046-2055.
5. Jorgensen C, Noel D, Gross G, (2002) Could inflammatory arthritis be triggered by progenitor cells in the joints? Ann Rheum Dis 61: 6-9.
6. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, et al. (2004) Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50: 817-827.
7. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP, (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942.
8. Li X, Makarov SS, (2006) An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes. Proc Natl Acad Sci U S A 103: 17432-17437.
9. Nakashima K, Zhou X, Kunkel G, Zhang ZP, Deng JM, et al. (2002) The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
10. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
11. Firestein GS, (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
12. Goldring SR, Gravallese EM, (2000) Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12: 195-199.
13. Li P, Schwarz EM, (2003) The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol 25: 19-33.
14. Lu X, Gilbert L, He X, Rubin J, Nanes MS, (2006) Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem 281: 6297-6306.
15. Gilbert L, He X, Farmer P, Rubin J, Drissi H, et al. (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277: 2695-2701.
16. Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, et al. (2006) Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 281: 4326-4333.
17. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D, (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278: 27939-27944.
18. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, et al. (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7: 803-812.
19. Ayroldi E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, et al. (2001) Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98: 743-753.
20. Mittelstadt PR, Ashwell JD, (2001) Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276: 29603-29610.
21. Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, et al. (2002) Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 22: 7929-7941.
22. Ayroldi E, Zollo O, Bastianelli A, Marchetti C, Agostini M, et al. (2007) GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Invest 117: 1605-1615.
23. Zhang W, Yang N, Shi XM, (2008) Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem 283: 4723-4729.
24. Yang N, Zhang W, Shi XM, (2007) Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J Cell Biochem 103: 1760-1771.
25. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, et al. (2001) Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20: 7108-7116.
26. Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, et al. (2010) Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 11: 517-531.
27. Drissi H, Pouliot A, Koolloos C, Stein JL, Lian JB, et al. (2002) 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp Cell Res 274: 323-333.
28. Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, et al. (2009) Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 284: 35987-35995.
29. FitzGerald GA, Patrono C, (2001) Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345: 433-442.
30. Conn DL, (2001) Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis. Arthritis Rheum 45: 462-467.
31. Harris ED, Emkey RD Jr, Nichols JE, Newberg A, (1983) Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 10: 713-721.
32. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW, (2002) Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-Blind, placebo-controlled clinical trial. Ann Intern Med 136: 1-12.
33. Ayroldi E, Riccardi C, (2009) Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 23: 1-10.
34. Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, Zuraw BL, (2007) The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119: 115-122.
35. Cohen N, Mouly E, Hamdi H, Maillot MC, Pallardy M, et al. (2006) GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107: 2037-2044.
36. Beaulieu E, Ngo D, Santos L, Yang YH, Smith M, et al. (2010) Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum 62: 2651-2661.
37. Lacey DC, Simmons PJ, Graves SE, Hamilton JA, (2009) Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 17: 735-742.
38. Zhang W, Ou G, Hamrick M, Hill W, Borke J, et al. (2008) Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res 23: 1118-1128.